Noriyoshi Omori
About Noriyoshi Omori
Noriyoshi Omori is the Associate Director at Bristol-Myers Squibb, with over 20 years of experience in the pharmaceutical and healthcare industry.
Current Position at Bristol-Myers Squibb
Noriyoshi Omori holds the position of Associate Director at Bristol-Myers Squibb. He has been with the company for over 7 years, having joined in December 2016. His role involves various responsibilities typical of an Associate Director, focused on advancing the company's objectives in the pharmaceutical and healthcare sectors.
Previous Roles at IMS Japan K.K.
Prior to his current role, Noriyoshi Omori worked at IMS Japan K.K. in several managerial capacities. From 2010 to 2016, he served as Senior Manager, and from 2004 to 2010, he held the position of Account Manager. His 12-year tenure at IMS Japan K.K. provided him with considerable experience in managing accounts and leading teams within the healthcare industry.
Early Career at Okamoto Industries
Noriyoshi Omori began his professional journey at Okamoto Industries, where he spent 7 years in a sales position. During his time there, from 1997 to 2004, he developed foundational skills in sales and customer relations, which later proved valuable in his subsequent roles in the pharmaceutical sector.
Educational Background at Waseda University
Noriyoshi Omori is an alumnus of Waseda University, where he achieved a Master of Business Administration (MBA) from 2008 to 2009. Additionally, he completed his undergraduate studies at Waseda University from 1994 to 1997. His education provided a strong foundation in business principles and management strategies, supporting his extensive career in the healthcare industry.
Over 20 Years of Experience in the Pharmaceutical Industry
With over 20 years in the pharmaceutical and healthcare industry, Noriyoshi Omori has built a robust career marked by various leadership roles. His extensive experience spans sales, account management, and senior managerial positions, highlighting his expertise and commitment to the industry.